Published in Women's Health Weekly, July 22nd, 2004
K. Yudoh and associates at St. Marianna University, Japan, wrote, "Previously, we showed that human osteoblasts expressing the human telomerase reverse transcriptase (hTERT) gene exhibited specific survival advantages - the result of breaching the replicative senescence barrier and maintaining the phenotypic and functional properties of primary osteoblasts in vitro over the total replicative capacity of primary osteoblasts."
In that study the researchers "postulated that rejuvenated osteoblasts may have a potential to correct bone loss or osteopenia in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.